BGB-3111-112
Completed
The Effect of Moderate CYP3A Inducer Rifabutin on the Pharmacokinetics of Zanubrutinib in Healthy Males
Beigene Study ID 
BGB-3111-112
ClinicalTrials.gov ID
Sex:
Male
Age: 18 Years to 65 Years (Adult, Older Adult)
Accepts Healthy Volunteers? yes
No Study Documents
Sex:
Male
Age: 18 Years to 65 Years (Adult, Older Adult)
Accepts Healthy Volunteers? yes
No Study Documents
BeiGene provides links to web sites of other organizations in order to provide visitors with certain information. A link does not constitute an endorsement of content, viewpoint, policies, products or services of that web site. Once you link to another web site not maintained byBeiGene Australia, you are subject to the terms and conditions of that web site, including but not limited to its privacy policy.
Click the link above to continue or CANCEL